Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,623 shares vested on February 4, 2023. F5 · derivative.expiration_date: 3,623 shares vested on February 4, 2023. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 1,905 | $89.70 | $170,878.50 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,354 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 3,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,259 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 4,268 shares vested on February 4, 2023. F5 · derivative.expiration_date: 4,268 shares vested on February 4, 2023. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,925 shares vested on February 4, 2023. F4 · derivative.expiration_date: 3,925 shares vested on February 4, 2023. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 2,117 | $89.70 | $189,894.90 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,394 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,511 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 1,947 | $89.70 | $174,645.90 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,243 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,190 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007502 · doc4.xml · derivative · entry 5 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,795 Underlying: Common Stock · 3,795 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,795 shares vested on February 3, 2023; the remaining 3,795 shares will vest on February 3, 2024. F4 · derivative.expiration_date: 3,795 shares vested on February 3, 2023; the remaining 3,795 shares will vest on February 3, 2024. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 1,882 | $89.70 | $168,815.40 |
DisclosureSEC source: 0001209191-23-007502 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,491 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 3,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007502 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,373 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,660 Underlying: Common Stock · 1,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,660 shares vested on February 3, 2023; the remaining 1,660 shares will vest on February 3, 2024. F4 · derivative.expiration_date: 1,660 shares vested on February 3, 2023; the remaining 1,660 shares will vest on February 3, 2024. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 873 | $89.70 | $78,308.10 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,636 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 16:15 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007504 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,509 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:55 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006320 · doc4.xml · derivative · entry 6 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,232 Underlying: Common Stock · 1,115 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,115 shares vested on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025. F5 · derivative.expiration_date: 1,115 shares vested on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:55 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 553 | $88.51 | $48,946.03 |
DisclosureSEC source: 0001209191-23-006320 · doc4.xml · nonDerivative · entry 4 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,578 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:55 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 1,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006320 · doc4.xml · nonDerivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,131 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:56 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006322 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 879 shares vested on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025. F5 · derivative.expiration_date: 879 shares vested on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:56 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 463 | $88.51 | $40,980.13 |
DisclosureSEC source: 0001209191-23-006322 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,849 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:56 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006322 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,312 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313 Underlying: Common Stock · 1,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 1,312 shares vested on February 1, 2023; and 1,313 shares will vest on February 1, 2024. F6 · derivative.expiration_date: 1,312 shares vested on February 1, 2023; and 1,313 shares will vest on February 1, 2024. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 651 | $88.51 | $57,620.01 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,265 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F3 · balance_after: The amount of securities beneficially owned following this transaction include an additional 51 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · derivative · entry 6 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947 Underlying: Common Stock · 473 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 473 shares vested on February 1, 2023; 473 shares will vest on February 1, 2024; and 474 shares will vest on February 1, 2025. F5 · derivative.expiration_date: 473 shares vested on February 1, 2023; 473 shares will vest on February 1, 2024; and 474 shares will vest on February 1, 2025. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 162 | $88.51 | $14,338.62 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 4 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,301 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,463 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:55 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006320 · doc4.xml · derivative · entry 5 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,283 Underlying: Common Stock · 6,760 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 6,760 shares vested on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 6,760 shares vested on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:55 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 3,406 | $85.61 | $291,587.66 |
DisclosureSEC source: 0001209191-23-006320 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,016 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:55 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 6,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006320 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,422 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:56 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006322 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,659 Underlying: Common Stock · 3,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,219 shares vested on January 31, 2023; 3,219 shares will vest on January 31, 2024; and 3,220 shares will vest on each of January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 3,219 shares vested on January 31, 2023; 3,219 shares will vest on January 31, 2024; and 3,220 shares will vest on each of January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:56 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 1,771 | $85.61 | $151,615.31 |
DisclosureSEC source: 0001209191-23-006322 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,433 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:56 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 3,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006322 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,204 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,095 Underlying: Common Stock · 3,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,547 shares vested on January 31, 2023; 3,547 shares will vest on January 31, 2024; and 3,548 shares will vest on January 31, 2025. F5 · derivative.expiration_date: 3,547 shares vested on January 31, 2023; 3,547 shares will vest on January 31, 2024; and 3,548 shares will vest on January 31, 2025. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 1,840 | $85.61 | $157,522.40 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,553 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,393 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · derivative · entry 5 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,830 Underlying: Common Stock · 1,609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,609 shares vested on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 1,609 shares vested on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 643 | $85.61 | $55,047.23 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,990 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 1,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,633 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 30, 2023 Filed Jul 1, 2024 20:46 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantNon-Qualified Stock Option · Derivative | 21,012 | $0.00 Strike: $119.06 | $0.00 |
DisclosureSEC source: 0000950170-24-079927 · ownership.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,012 Underlying: Common Stock · 21,012 shares Expires 2030-07-07 F1 · derivative.exercise_date: The stock option was originally granted to the Reporting Person on July 7, 2020. Its terms were amended on January 30, 2023 to remove the performance conditions and provide that the stock option would vest in its entirety on December 31, 2023, subject to the Reporting Person's continued service through such date. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:18 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000192 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68 Underlying: Common Stock · 69 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: 69 shares vested on December 31, 2022; the remaining 68 shares will vest on March 31, 2023. F3 · derivative.expiration_date: 69 shares vested on December 31, 2022; the remaining 68 shares will vest on March 31, 2023. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:18 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000192 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059643 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476 Underlying: Common Stock · 238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 238 shares vested on December 1, 2022; the remaining 476 shares will vest in equal installments on December 1, 2023 and December 1, 2024. F4 · derivative.expiration_date: 238 shares vested on December 1, 2022; the remaining 476 shares will vest in equal installments on December 1, 2023 and December 1, 2024. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 119 | $93.65 | $11,144.35 |
DisclosureSEC source: 0001209191-22-059643 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,024 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059643 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,143 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 16:26 UTC |
Bujarski Robert JosephPresident & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058146 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,033 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,033 shares vested on November 18, 2022. F4 · derivative.expiration_date: 1,033 shares vested on November 18, 2022. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 16:26 UTC |
Bujarski Robert JosephPresident & COO
|
Tax withholdingCommon Stock | 544 | $88.40 | $48,089.60 |
DisclosureSEC source: 0001209191-22-058146 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,985 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 16:26 UTC |
Bujarski Robert JosephPresident & COO
|
GrantCommon Stock | 1,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058146 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,529 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056365 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940 Underlying: Common Stock · 3,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,970 shares vested on November 8, 2022; the remaining 7,940 shares will vest in equal installments on November 8, 2023 and November 8, 2024. F4 · derivative.expiration_date: 3,970 shares vested on November 8, 2022; the remaining 7,940 shares will vest in equal installments on November 8, 2023 and November 8, 2024. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 1,969 | $87.69 | $172,661.61 |
DisclosureSEC source: 0001209191-22-056365 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,905 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.